Plain-English translation of NCT07039942 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is following people with type 1 diabetes who use the Omnipod 5 automated insulin pump system for one year. The Omnipod 5 is a wearable insulin pump that automatically adjusts insulin doses based on continuous glucose monitoring readings. Researchers want to understand how well this system controls blood sugar, improves quality of life, and how safely and effectively people use it in their daily routines.
While this medication has been approved for use, real-world data from actual patients using it in their everyday lives—outside of controlled research settings—is valuable for understanding how it truly performs, what challenges people face, and how it affects overall wellbeing.
You will use the Omnipod 5 system in your normal daily life for 12 months while the research team follows your progress. During this time, you will complete questionnaires about your blood sugar control, quality of life, and how you are using the device—usually through electronic surveys. You will have visits with your healthcare provider at the study site to check in on your progress, safety, and how well the system is working for you.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
France